| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021675584 |
| P356 | DOI | 10.1038/SJ.GT.3301104 |
| P698 | PubMed publication ID | 10694824 |
| P5875 | ResearchGate publication ID | 12620456 |
| P2093 | author name string | Matsumoto K | |
| Nakamura T | |||
| Kaneda Y | |||
| Aoki M | |||
| Higaki J | |||
| Morishita R | |||
| Ogihara T | |||
| Taniyama Y | |||
| Kida I | |||
| Moriguchi A | |||
| P2860 | cites work | Molecular cloning and expression of human hepatocyte growth factor | Q24305558 |
| Nitric oxide synthase modulates angiogenesis in response to tissue ischemia | Q28508302 | ||
| Novel and effective gene transfer technique for study of vascular renin angiotensin system | Q30449287 | ||
| Organization of the human hepatocyte growth factor-encoding gene | Q33322063 | ||
| The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation | Q33767307 | ||
| A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo | Q34159206 | ||
| Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis | Q34292693 | ||
| Vasculogenesis | Q34387300 | ||
| The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation | Q36479295 | ||
| Oncogenic conversion by regulatory changes in transcription factors | Q37625802 | ||
| In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction | Q38343941 | ||
| Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells | Q38351143 | ||
| Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. | Q38358011 | ||
| Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease | Q39465201 | ||
| Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes | Q40017265 | ||
| Recent advances in the application of gene therapy to human disease | Q40373834 | ||
| Emerging multipotent aspects of hepatocyte growth factor | Q41066829 | ||
| Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth | Q41596252 | ||
| Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration | Q41641693 | ||
| Estimation of Infarct Size in Man and its Relation to Prognosis | Q44019462 | ||
| Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (Hemagglutinating Virus of Japan)--liposome method | Q45762989 | ||
| Human gene therapy protocols: RAC review | Q45869204 | ||
| RAC's review of gene therapy: it's time to move on. | Q45870400 | ||
| In vivo transfer efficiency of antisense oligonucleotides into the myocardium using HVJ-liposome method | Q45881047 | ||
| Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the beta-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area | Q45881115 | ||
| Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells | Q45889537 | ||
| In Vivo Activation of met Tyrosine Kinase by Heterodimeric Hepatocyte Growth Factor Molecule Promotes Angiogenesis | Q58831780 | ||
| Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor | Q67542808 | ||
| A novel modulator domain of Ets transcription factors | Q68134655 | ||
| Increased expression of DNA cointroduced with nuclear protein in adult rat liver | Q69937795 | ||
| Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells | Q71016612 | ||
| A vascular modulator, hepatocyte growth factor, is associated with systolic pressure | Q71506843 | ||
| Expression of local hepatocyte growth factor system in vascular tissues | Q71560574 | ||
| Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor | Q71953088 | ||
| Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model | Q73418656 | ||
| Actions of hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease | Q74130596 | ||
| Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart | Q77953199 | ||
| P433 | issue | 5 | |
| P921 | main subject | angiogenesis | Q539568 |
| P304 | page(s) | 417-427 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. | |
| P478 | volume | 7 |
| Q39584378 | A mouse model for spatial and temporal expression of HGF in the heart. |
| Q45730070 | A novel method of augmenting gene expression and angiogenesis in the normal and ischemic canine myocardium |
| Q33676193 | Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET |
| Q36376726 | Adenovirus-mediated transfer of hepatocyte growth factor gene to human dental pulp stem cells under good manufacturing practice improves their potential for periodontal regeneration in swine |
| Q35879185 | Adipose stromal vascular fraction cell construct sustains coronary microvascular function after acute myocardial infarction |
| Q34512008 | Advances in gene therapy of liver cirrhosis: a review |
| Q44615189 | Age-related changes in the mitotic and metabolic characteristics of muscle-derived cells |
| Q39753947 | Agonist monoclonal antibodies against HGF receptor protect cardiac muscle cells from apoptosis. |
| Q34515181 | Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy. |
| Q55344494 | Angiogenic and pleiotropic effects of VEGF165 and HGF combined gene therapy in a rat model of myocardial infarction. |
| Q31805054 | Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation |
| Q50982738 | Anxiolytic effect of hepatocyte growth factor infused into rat brain. |
| Q33552206 | Assessment of myocardial blood perfusion improved by CD151 in a pig myocardial infarction model |
| Q43486510 | Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia |
| Q34272428 | Bone marrow mesenchymal stem cells overexpressing human basic fibroblast growth factor increase vasculogenesis in ischemic rats |
| Q92728117 | Cardiac fibrosis: potential therapeutic targets |
| Q34542255 | Catheter-based intramyocardial delivery (NavX) of adenovirus achieves safe and accurate gene transfer in pigs |
| Q37848468 | Cellular/extracellular matrix cross-talk in scar evolution and control. |
| Q44770937 | Combined administration of basic fibroblast growth factor protein and the hepatocyte growth factor gene enhances the regeneration of dermis in acute incisional wounds |
| Q42157765 | Cross talk of the first-line defense TLRs with PI3K/Akt pathway, in preconditioning therapeutic approach |
| Q36823697 | Current status of cardiovascular gene therapy |
| Q45885266 | Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. |
| Q36075155 | Does gene therapy become pharmacotherapy? |
| Q45726385 | Efficient gene transfer from innervated muscle into rat peripheral and central nervous systems using a non‐viral haemagglutinating virus of Japan (HVJ)‐liposome method |
| Q37157213 | Exercise training and peripheral arterial disease |
| Q45875674 | Experimental research on therapeutic angiogenesis induced by hepatocyte growth factor directed by ultrasound-targeted microbubble destruction in rats |
| Q30427066 | Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications |
| Q24632135 | Gene therapy for ischemic heart disease |
| Q45879267 | Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons. |
| Q34319721 | Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic |
| Q34453212 | Gene therapy in vascular medicine: recent advances and future perspectives |
| Q40787116 | Gene therapy of ischemic-damaged kidney in the rat using hepatocyte growth factor gene |
| Q36477718 | Gene therapy of the ischemic lower limb--Therapeutic angiogenesis. |
| Q35069562 | Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia |
| Q35937557 | Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia |
| Q73233056 | Gene transfer of hepatocyte growth factor improves angiogenesis and function of chronic ischemic myocardium in canine heart |
| Q35747709 | Gene transfer of human hepatocyte growth factor into rat skin wounds mediated by liposomes coated with the sendai virus (hemagglutinating virus of Japan). |
| Q51688953 | HGF expression induced by HIF-1α promote the proliferation and tube formation of endothelial progenitor cells. |
| Q36681433 | HGF percutaneous endocardial injection induces cardiomyocyte proliferation and rescues cardiac function in pigs |
| Q54256769 | HGF/Met Axis in Heart Function and Cardioprotection. |
| Q40177792 | Hepatocyte growth factor accelerates thrombopoiesis in transgenic mice |
| Q55069823 | Hepatocyte growth factor and carotid intima-media thickness in relation to circulating CD34-positive cell levels. |
| Q36124924 | Hepatocyte growth factor as potential cardiovascular therapy |
| Q45855638 | Hepatocyte growth factor gene-modified bone marrow-derived mesenchymal stem cells transplantation promotes angiogenesis in a rat model of hindlimb ischemia |
| Q74465128 | Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques |
| Q42515762 | Hepatocyte growth factor is produced by blood and alveolar neutrophils in acute respiratory failure |
| Q51817888 | Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. |
| Q33555638 | Hepatocyte growth factor protects endothelial cells against gamma ray irradiation-induced damage |
| Q35011205 | Hepatocyte growth factor-mediated attraction of mesenchymal stem cells for apoptotic neuronal and cardiomyocytic cells |
| Q30596582 | Intramyocardial injection of a synthetic hydrogel with delivery of bFGF and IGF1 in a rat model of ischemic cardiomyopathy |
| Q44231378 | Liver regeneration is an angiogenesis- associated phenomenon |
| Q37343997 | Long-term Angiogenesis Efficacy Using a Heparin-Conjugated Fibrin (HCF) Delivery System with HBM-MSCs. |
| Q36254989 | Lysine: Is it worth more? |
| Q40761395 | Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. |
| Q36067773 | Necrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death. |
| Q36040865 | Nitric oxide and the angiogenic response: can we improve the results of therapeutic angiogenesis? |
| Q38028448 | Nonviral gene therapy targeting cardiovascular system |
| Q33712995 | Nonviral retrograde gene transfer of human hepatocyte growth factor improves neuropathic pain-related phenomena in rats |
| Q28305555 | Novel therapy for myocardial infarction: can HGF/Met be beneficial? |
| Q28288230 | Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease |
| Q38087578 | Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success |
| Q45858394 | Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia |
| Q34114279 | Recent developments in gene therapy for cardiac disease |
| Q41940674 | Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis |
| Q48617387 | Serum ghrelin levels and the effects of antidepressants in major depressive disorder and panic disorder |
| Q37035997 | Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic |
| Q38308665 | Src-mediated activation of alpha-diacylglycerol kinase is required for hepatocyte growth factor-induced cell motility. |
| Q36466672 | Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D. |
| Q51767582 | Tamoxifen treatment of myocardial infarcted female rats exacerbates scar formation. |
| Q38234910 | Targeting pleiotropic signaling pathways to control adult cardiac stem cell fate and function. |
| Q24609298 | The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine |
| Q35949643 | Therapeutic myocardial angiogenesis: past, present and future |
| Q38312563 | Therapeutic potential of hepatocyte growth factor against cerebral ischemia (Review). |
| Q92677843 | Tissue Engineering of the Microvasculature |
| Q33889422 | hHGF overexpression in myoblast sheets enhances their angiogenic potential in rat chronic heart failure |
Search more.